Palliative sedation for the relief of refractory physical symptoms

Progress in Palliative Care

Volumn 16, Issue 1, 2008, Pages 51-62

  Cherny, Nathan I ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Double effect; End of life; Ethics; Palliative sedation

Indexed keywords

AMOBARBITAL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; LEVOMEPROMAZINE; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; PROPOFOL; THIOPENTAL;

ADVANCED CANCER; AGITATION; ASSISTED SUICIDE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTINUOUS INFUSION; DELIRIUM; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EUTHANASIA; HUMAN; HYDRATION; INFORMED CONSENT; LOADING DRUG DOSE; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MONOTHERAPY; MYOCLONUS; NUTRITION; ORTHOSTATIC HYPOTENSION; PAIN; PALLIATIVE THERAPY; PATIENT CONTROLLED ANALGESIA; PATIENT MONITORING; PATIENT SATISFACTION; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; TERMINAL CARE; TERMINAL DISEASE; TREATMENT PLANNING;

EID: 49749140423     PISSN: 09699260     EISSN: None     Source Type: Journal    
DOI: 10.1179/096992608X291234     Document Type: Review

References (102)

1. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: Guidelines for, eviluation and treatment. J Palliat Care 1994; 10: 31-38
2. del Rosario. MA, Martin AS, Ortega JJ, Feria M. Temporary sedation with midazolam for control of severe incident pain. J Pain Symptonr Managa 2001; 21: 439-442.
3. de Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards. J Palliat Med 2007; 10: 67-85.
4. Rousseau PC. Palliative sedation. Am J Hosp Palliat Care 2002; 19: 195-297.
5. Jackson WC. Palliative sedation vs. terminal sedation: What's in a name? Am J Hosp Palliat Care 2002; 19: 81-42.
6. Beel A, McClement SE, Harlos, M. Palliative sedation therapy: A review of definitions and usage. Int J Pallial Nurs 2002; 8: 190-199.
7. Cowan JD, Walsh D. Terminal sedation in palliative medicine - definition and review of the literature. Support Care Cancer 2001; 9: 403-407.
8. Mercadante S. Pain treatment and outcomes for:pAtients with advanced cancer who receive follow-up care at home [see comments]. Cancer 1999; 85: 1849-1858.
9. Salisbury C, Bosanquet N, Wilkinson EK et al. The impact of different models of specialist palliative care on patients' quality of life: A systematic literature review. Palliat Med 1999; 13: 3-17.
10. Higginson IJ, Wade AM, McCarthy M. Effectiveness of two palliative support teams. .J Public Health Med 1992; 14: 50-56.
11. Higginson IJ, McGregor AM. The impact of palliative medicine? [editorial]. Palliat Med 1999; 13: 285-299.
12. Peruselli C, Di Giulio P. Toscani F et al. Home palliative care for terminal cancer patients: A survey on the final week of life. Palliat Med 1999; 13: 233-241.
13. Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain Symptom Manage 1997; 14: 29-35.
14. Conill C. Verger E,.Henriquez I et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997; 14: 328-331.
15. Storey P. Symptom control in advanced cancer. Semin Oncol 1994; 21: 748-753.
16. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990; 6: 7-15.
17. Johanson G.A., Symptom character and prevalence during cancer patients' last days of life. Am J Hosp Palliat Care 1991; 8: 6-8 18.
18. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer. AIDS. heart disease. chronic obstructive pulmonary disease and renal disease. J Pain Symtom Manage 2006; 31: 58-69.
19. Enck RE. Drug-induced terminal sedation for symptorn control. Am. J Hosp Palliat Care 1991; 8: 3-5.
20. Roy DJ. Need they sleep before they die? J Palliat Care 1990: 6: 3-4.
21. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990: 6: 7-11.
22. Mount-B. A final crescendo of pain? J Palliat Care 1990; 6: 5-6.
23. Fainsinger R. Miller MJ, Bruera E. Ilanson J, Maccachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991: 7: 5-11.
24. Morita T. Inoue S, Chihara S. Sedation for symptom control in Japan: The importance of intermittent use and communication with family members. J Pain Symptom Manage 1996; 12: 32-38
25. Stone P. Phillips C, Spruyt O, Waight C. Acomparison of the use of sedatives in a hospital support team and in a hospice. Pallial Med 1997; 11: 140-144.
26. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998; 16: 145-152.
27. Coyle N. The last four weeks of life. Am J Nurs 1990; 90: 75-6, 78.
28. Ambrosinu N, Simonds. A. The clinical management, in extremely severe COPD. Respir Med 2007; 101: 1613-1624.
29. Jakob SM, Lubszky S, Friolet R, Rothen HU, Kolarova A, Takala J. Sedation and weaning from mechanical ventilation: Effects of process optimization outside a clinical trial. J Crit Care 2007; 22: 219-228.
30. Reisfield GM, Wilson GR. Palliative care issues in heart failure #144. J Palliat Med 2007; 10: 247-248.
31. Goodlin SJ. Palliative care for end-stage heart failure. Curr Heart Fail Rep 2005; 2: 155-160.
32. Low JA,Pang WS, Chan DK, Chye R. A palliative care approach to end-stage neurodegenerative conditions. Ann Acad Mcd Singapore 2003; 32: 778-784.
33. Elman LB, Houghton DJ, Wu GF, Hurtig HI, Markowitz CE, McCluskey L. Palliative care in amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. J Palliat Med 2007; 10: 433-457
34. Feldman HA, McKinlay JB, Potter DA el al. Nonmedical influences on medical decision making: An experimental technique using videotapes, factorial design, and survey sampling. Health Serv Res 1997; 32: 343-366.
35. Cliristakis NA, Asch DA. Biases in how physicians choose to withdraw life support. Lancet 1993; 342: 642-646.
36. Wem S. Sedation in the imminently dying patient. Oncology (Funtingi) 2000; 14: 585-592, discussion 592, 597-598, 601.
37. Braun TC, Hagen NA, Clark T. Development of a clinical practice guideline for palliative sedation. J Palliat Med 2003; 6: 345-350.
38. Haines IE, Zalcberg J, Buchanan JD. Not-for-resuscitation orders in cancer patients - principles of decision-making. Med J Aust 1990; 153: 225-229.
39. Rosner F, Kark PR, Bennett AJ et al. Medical futility. Committee on Bioethical Issues of the Medical Society of the State of New York. NY State J Med 1992; 92: 485-488.
40. Marik PE, Zaloga GP. CPR in terminally ill patients? Resuscitation 2001; 49: 99-103.
41. Portenoy RK. Continuous intravenous infusion of opioid drugs. Med Clin North Am 1987; 71: 233-241.
42. Potter JM, Reid DB, Shaw RJ, Hackett P, Hickman PE. Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs [see comments]. BMJ 1989; 299: 150-153.
43. Dunlop RJ. Excitatory phenomena associated with high dose opioids. Curr Ther 1989; 30: 121-123.
44. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998; 12: 255-269.
45. Nordt SP, Clark RF. Midazolam: A review of therapeutic uses and toxicity. J Fmerg Med 1997; 15: 357-365.
46. Burke AL. Palliative care: An update on 'terminal restlessness'. Med J Aust 1997; 166: 39-42.
47. Collins P. Prolonged sedation with midazolam or propofol [letter: comment]. Crit Care Med 1997; 25: 556-557.
48. Johanson GA. Midazolam in terminal care. Am J Hosp Palliai Care 1993; 10: 13-14.
49. Power D, Kearney M. Management of the final 24 hours. Ir Med J 1992; 85: 93-95.
50. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA. Terminal restlessness - its management and the role of midazolam [see comments]. Med J Aust 1991; 155: 485-487.
51. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 1991; 84: 332-337.
52. Truog RD, Berde CB, Mitchell C, Grier HE. Barbiturates in the care of the terminally ill. N Engl J Med 1992; 327: 1678-1682
53. Oliver DJ. The use of methotrimeprazine in terminal care. Br J Clin Pract 1985; 39: 339-340.
54. O'Neill J, Fountain A. Levomepromazine (methotrimeprazine) and the last 48 hours. Hosp Med 1999; 60: 568-570.
55. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994; 9: 341-345.
56. LeGrand SB. Dyspnea: The continuing challenge of palliative mangement. Curr Opin Oncol 2002; 14: 294-398.
57. Tobias JD. Propofol sedation for terminal care in a pediatric patient. Clin Pediatr (Phila) 1997; 36: 291-293.
58. Krakauer EL, Penson RT, Truog RD, King LA, Chabner BA, Lynch Jr TJ. Sedation for intractable distress of a dying patient: Acute palliative care and the principle of double effect. Oncologist 2000; 5: 53-62.
59. Mercadante S, De Conno F, Ripamonti C. Propofol in terminal care. J Pain Symptom Manage 1995; 10: 639-642.
60. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage 1995; 10: 643-646.
61. Quill TE, Lo B, Brock DW. Palliative options of last resort: A comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA 1997; 278: 2099-2104.
62. Quill TE, Byock IR. Responding to intractable terminal suffering: The role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 2000; 132: 408-414.
63. Orentlicher D, Caplan A. The-Pain Relief Promotion Act of 1999: A serious threat to palliative care. J Am Acad Psychiatry Law 1999; 27: 527-539. discussion 540-545.
64. Bozzetti F, Amadori D, Bruera E et al. Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition 1996; 12: 163-167.
65. Jansen LA, Sulmasy DP. Sedation, alimentation, hydration, and equivocation: Careful conversation about care at the end of life. Ann Intern Med 2002; 136: 845-849.
66. Craig GM. On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues [published erratum appears in J Med Ethics 1996; 22: 361].
67. Craig GM. J Med Ethics 1996; 22: 147-153.
68. Ashby M, Stoffell B. Artificial hydration and alimentation at the end of life: A reply to Craig. J Med Ethics 1995; 21: 135-140
69. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin 2004; 20: 403-417, viii-ix.
70. Kress JP, Hall JB. Delirium and sedation. Crit Care Clin 2004; 20: 419-433, ix.
71. Miller FG, Fins JJ, Bacchetta MD. Clinical pragmatism: John Dewey and clinical ethics. J Contemp Health Law Policy 1996; 13: 27-51.
72. Fins JJ, Bacchetta MD, Miller FG. Clinical pragmatism: A method of moral problem solving. Kennedy Inst Ethics J 1997; 7: 129-145
73. Gevers S. Terminal sedation: A legal approach. Eur J Health Law 2003; 10: 359-367.
74. Devlin P. Easing the Passing. London: Bodley Head, 1985.
75. Burt RA. The Supreme Court speaks - not assisted suicide but a constitutional right to palliative care. N Engl J Med 1997; 337: 1234-1236.
76. van der Maas PJ, van Delden JJ, Pijnenborg L. Euthanasia and other medical decisions concerning the end of life. An investigation performed upon request of the Commission of Inquiry into the Medical Practice concerning Euthanasia. Health Policy 1992, 21: Vi-x, 1-262.
77. van der Maas PJ, van der Wal G, Haverkate I et al. Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in The Netherlands, 1990-1995 [see comments]. N Engl J Med 1996; 335: 1699-1705.
78. Rietjens JA, van der Heide A, Vrakking AM, Onwuteaka-Philipsen BD, van der Maas PJ, van der Wal G. Physician reports of terminal sedation without hydration or nutrition for patients nearing death in The Netherlands. Ann Intern Med 2004; 141: 178-185.
79. Kuhse H, Singer P, Baume P, Clark M, Rickard M. End-of-life decisions in Australian medical practice. Med J Aust 1997; 166: 191-196.
80. Stevens CA, Hassan R. Management of death, dying and euthanasia: attitudes and practices of medical practitioners in South Australia. Arch Intern Med 1994; 154: 575-584.
81. Willems DL, Daniels ER, van der Wal G, van der Maas PJ, Emanuel EJ. Attitudes and practices concerning the end of life: A comparison between physicians from the United States and from The Netherlands. Arch Intern Med 2000; 160: 63-68.
82. Meier DE, Emmons CA, Wallenstein S, Quill T, Morrison RS, Cassel CK. A national survey of physician-assisted suicide and euthanasia in the United States [see comments]. N Engl J Med 1998; 338: 1193-1201.
83. Douglas CD, Kerridge IH, Rainbird KJ, McPhee JR, Hancock L, Spigelman AD. The intention to hasten death: A survey of attitudes and practices of surgeons in Australia. Med J Aust 2001; 175: 511-515
84. van der Heide A, Deliens L, Faisst K et al. End-of-life decision-making in six European countries: Descriptive study. Lancet 2003; 362: 345-350.
85. Craig GM. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? [see comments]. J Med Ethics 1994; 20: 139-143, discussion 144-145.
86. Craig G. Is sedation without hydration or nourishment in terminal care lawful? Med Leg J 1994; 62: 198-201.
87. Orentlicher D. The Supreme Court and physician-assisted suicide - rejecting assisted suicide but embracing euthanasia. N Engl J Med 1997; 337: 1236-1239.
88. Brody H. Causing, intending, and assisting death. J Clin Ethics 1993; 4: 112-117.
89. Sulmasy DP, Ury WA, Ahronheim JC et al. Palliative treatment of last resort and assisted suicide. Ann Intern Med 2000; 133: 562-563.
90. Boyle J. Medical ethics and double effect: The case of terminal sedation. Theor Med Bioeth 2004; 25: 51-60.
91. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001; 21: 467-472.
92. Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003; 163: 341-344.
93. Daly BJ, Thomas D, Dyer MA. Procedures used in withdrawal of mechanical ventilation [see comments]. Am J Crit Care 1996; 5: 331-33-8.
94. Campbell ML, Bizek KS, Thill M. Patient responses during rapid terminal weaning from mechanical ventilation: A prospective study [see comments]. Crit Care Med 1999; 27: 73-77.
95. Wilson WC, Smedira NG, Fink C, McDowell JA, Luce JM. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients [see comments]. JAMA 1992; 267: 949-953.
96. Quill TE, Dresser R, Brock DW. The rule of double effect - a critique of its role in end-of-life decision making. N Engl J Med 1997; 337: 1768-1771.
97. Ahronheim JC. Nutrition and hydration in the terminal patient. Clin Geriatr Med 1996; 12: 379-391.
98. Barber MD, Fearon KC, Delmore G, Loprinzi CL. Should cancer patients with incurable disease receive parenteral or enteral nutritional support? Eur J Cancer 1998; 34: 279-285.
99. Koshuta MA, Schmitz PJ, Lynn J. Development of an institutional policy on artificial hydration and nutrition. Kennedy Inst Ethics J 1991; 1: 133-139, discussion 139-140.
100. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001; 21: 467-472.
101. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care - a critical analysis of 7 years' experience. BMC Palliat Care 2003; 2: 2.
102. Morita T. Differences in physician-reported practice in palliative sedation therapy. Support Care Cancer 2004; 8: 584-592